The scientific program of the 4th Kurdistan Hematology Summit spans Adult Hematology, Pediatric Hematology, Haemophilia & Bleeding Disorders, and Thalassemia & Hemoglobin Disorders — plus a signature panel format designed to change practice.
Hall 1 — Adult Hematology. Ten sessions spanning leukemia, myeloma, lymphoma, myeloid disease, benign hematology, thrombosis, cellular therapy and precision medicine.
Acute Myeloid Leukemia: Redefining the Treatment Journey
Multiple Myeloma: Moving the Finish Line
Lymphoma: A New Era Beyond Chemotherapy
Myeloproliferative Neoplasms: Beyond Symptom Control
Myelodysplastic Syndromes: The New Molecular Era
CLL: How Much Treatment Is Enough?
Benign Hematology: The Difficult Decisions
Thrombosis and Hemostasis: Beyond the Guidelines
Cellular Therapy and Transplantation: The New Ecosystem
Precision Hematology: From Sequencing to the Bedside
Hall 2 — Pediatric Hematology. Nine sessions covering childhood leukemia, hemoglobinopathies, bone marrow failure, bleeding and thrombosis in children, and the transition to adult care.
Childhood Leukemia: How Far Can We Push the Cure?
Pediatric AML: Beyond the Traditional Backbone
Hemoglobinopathies: From Lifelong Disease to the Possibility of Cure
Bone Marrow Failure: When the Marrow Goes Silent
The Bleeding Child: Beyond the Factor Level
Pediatric Thrombosis: The New Epidemic We Did Not Expect
Immune Cytopenias: When First-Line Therapy Fails
Pediatric Transplantation and Cellular Therapy: Who Needs What, and When?
From Childhood to Adulthood: The Hematology Transition Gap
Hall 3 — Haemophilia & Bleeding Disorders. Eight sessions on the treatment revolution in haemophilia, gene therapy, inhibitors, and bleeding disorders often missed by standard tests.
Haemophilia 2026: The Treatment Revolution Is Here
Gene Therapy: Promise, Reality, and the Questions That Remain
Inhibitors: The Battle Is Not Over
Zero Bleeds Is Not Enough
The Haemophilia Joint: Detecting Damage Before It Is Too Late
Women Bleed Too
The Bleeding Patient with Normal Tests
Acquired Haemophilia: The Emergency Nobody Expects
Hall 4 — Thalassemia & Hemoglobin Disorders. Twelve sessions spanning transfusion, iron overload, organ protection, gene therapy, transplantation, and the realities of an aging thalassemia population.
Thalassemia: From Chronic Disease to the Possibility of Cure
The Transfusion Dilemma: More Than Maintaining Hemoglobin
Iron Overload: The Damage We See and the Damage We Miss
The Thalassemia Heart: Protecting the Organ That Changed Survival
The Endocrine Price of Survival
The New Therapeutic Landscape: Beyond Supportive Care
Gene Therapy and Gene Editing: Is the Future Already Here?
Transplantation: Still the Standard of Cure?
Non-Transfusion-Dependent Thalassemia: The Disease We Underestimate
Pregnancy, Fertility & Thalassemia: The New Frontier of Survivorship
The Thalassemia Patient Is Getting Older
Prevention: Can We Imagine a Future Without New Severe Cases?
Signature Style Panel Sessions. A distinctive format built around debate, unsolved cases, and multi-specialist perspectives on the same patient.
Late-Breaking Hematology 2026: The most practice-changing studies and major hematology publications
Practice-Changing Abstracts: What Will I Do Differently — experts select studies that should change local practice
The Hematology Debate: Opposite strategies on one controversial clinical decision
The Unsolved Case: A complex real case revealed step by step, with live audience voting
The Ferritin Is 5,000 — What Now?
Complex Patient With: Hematologist, Radiologist, Cardiologist, Endocrinologist
One Patient, Three Roads to Cure: Each expert builds one integrated plan from a different perspective
A Young Adult with Transfusion-Dependent Beta-Thalassemia: Transplantation vs. Gene Therapy vs. Optimized Medical Therapy
From Erbil to the World: Can Innovation Reach Every Patient?
Access to MRI | Blood Safety | Chelation | New Drugs | Transplantation | Gene Therapy
A mix of formats designed to keep every session clinically relevant and interactive.
Expert-led lectures covering recent advances across all four scientific halls.
Opposing strategies on controversial decisions, and complex cases revealed step by step with live audience voting.
New research from across the region presented and discussed with the wider scientific community.
Hematologists, radiologists, cardiologists and endocrinologists building one integrated plan for the same patient.
The full session timetable will be published closer to the event. Register now to be notified as soon as it's available.